Anzeige
Mehr »
Login
Freitag, 01.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
200.000 Unzen pro Jahr: Die Goldaktie, die kurz davor steht, Geschichte zu schreiben
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 260904 | ISIN: US63888P4063 | Ticker-Symbol: NAH
Frankfurt
01.11.24
08:01 Uhr
5,350 Euro
0,000
0,00 %
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
NATURAL HEALTH TRENDS CORP Chart 1 Jahr
5-Tage-Chart
NATURAL HEALTH TRENDS CORP 5-Tage-Chart
RealtimeGeldBriefZeit
5,2005,50011:33
GlobeNewswire (Europe)
192 Leser
Artikel bewerten:
(1)

Natural Health Trends Corp.: Natural Health Trends Reports Third Quarter 2024 Financial Results

  • Total net sales increased sequentially and year-over-year during the third quarter of 2024
  • Improved operating bottom line for three consecutive quarters
  • Generated cash flows from operations before 2017 Tax Act installment of $514,000 during the first nine months of 2024
  • Declared a quarterly cash dividend of $0.20 per share

HONG KONG, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and "quality of life" products under the NHT Global brand, today announced its financial results for the quarter ended September 30, 2024.

Third Quarter 2024 Financial Highlights

  • Revenue of $10.7 million increased 1% compared to $10.6 million in the third quarter of 2023.
  • Operating loss was $275,000 compared to $292,000 in the third quarter of 2023.
  • Net income was $35,000, or breakeven per diluted share, compared to $172,000, or $0.02 per diluted share, in the third quarter of 2023. The decrease was attributable to lower interest income and higher effective tax rate as compared to the third quarter of 2023.
  • The number of Active Members1 was down 1% to 30,880 at September 30, 2024 compared to 31,110 at June 30, 2024, and decreased 11% compared to 34,660 at September 30, 2023.

1 Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.

Year-to-Date 2024 Financial Highlights

  • Revenue of $32.1 million decreased 3% compared to $33.0 million in the first nine months of 2023.
  • Operating loss improved to $878,000 compared to $1.4 million in the first nine months of 2023.
  • Net income was $396,000, or $0.03 per diluted share, compared to $210,000, or $0.02 per diluted share, in the first nine months of 2023.

Management Commentary

"Consumer spending in our main market continues to be weak. However, we still managed to achieve sequential growth in net sales, as well as a year-over-year improvement in the third quarter. While the pace of growth is not where we'd like it to be, our customers and leaders continue to demonstrate strong engagement, and we are working closely with them to navigate these changing times with trainings, product roadshows and new products to help drive growth and expand their customer base," commented Chris Sharng, President of Natural Health Trends Corp.

Mr. Sharng continued, "Our ability to adapt, adjust programs, and fine-tune our plans has been instrumental in supporting our customer base while also acting in the best interests of our shareholders. We are maintaining attentive focus on cost control, including expense management, inventory, and product optimization, to ensure the company remains positioned for future success."

Balance Sheet and Cash Flow

  • Net cash used in operating activities was $3.5 million in the first nine months of 2024 compared to $4.2 million in the first nine months of 2023. Before tax installment payments, the liability of which arises from the 2017 U.S. Tax Cuts and Jobs Act (the "Tax Act"), cash provided by operating activities was $514,000 in the first nine months 2024, versus cash used in operating activities of $1.2 million in the comparable period a year ago. Of the total Tax Act liability of $20.2 million, $15.1 million has been paid to date.
  • Total cash, cash equivalents and marketable securities were $46.3 million at September 30, 2024, down from $48.7 million at June 30, 2024.
  • On October 28, 2024, the Company's Board of Directors declared a quarterly cash dividend of $0.20 on each share of common stock outstanding. The dividend will be payable on November 22, 2024 to stockholders of record as of November 12, 2024.

Third Quarter 2024 Financial Results Conference Call

Management will host a conference call to discuss the third quarter 2024 financial results today, Wednesday, October 30, 2024 at 11:30 a.m. Eastern Time. The conference call details are as follows:

Date:Wednesday, October 30, 2024
Time:11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
Dial-in:1-877-407-0789 (Domestic)
1-201-689-8562 (International)
Conference ID:13749004
Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1689949&tp_key=eea2c2882e

For those unable to participate during the live broadcast, a replay of the call will also be available from 2:30 p.m. Eastern Time on October 30, 2024 through 11:59 p.m. Eastern Time on November 6, 2024 by dialing 1-844-512-2921 (domestic) and 1-412-317-6671 (international) and referencing the replay pin number: 13749004.

About Natural Health Trends Corp.

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company's website at www.naturalhealthtrendscorp.com.

Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Such forward-looking statements are subject to risks and uncertainties that could cause the Company's actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption "Risk Factors" in Natural Health Trends Corp.'s Annual Report on Form 10-K filed on February 28, 2024 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

NATURAL HEALTH TRENDS CORP.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
September 30, 2024 December 31, 2023
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents$22,899 $56,178
Marketable securities 23,429 -
Inventories 3,684 4,293
Other current assets 3,830 3,758
Total current assets 53,842 64,229
Property and equipment, net 205 266
Operating lease right-of-use assets 2,784 3,319
Restricted cash 38 39
Deferred tax asset 307 369
Other assets 1,115 869
Total assets$58,291 $69,091
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable$548 $990
Income taxes payable 5,032 3,716
Accrued commissions 2,029 2,067
Other accrued expenses 1,350 1,170
Deferred revenue 6,832 6,166
Amounts held in eWallets 3,458 3,945
Operating lease liabilities 1,191 1,146
Other current liabilities 672 784
Total current liabilities 21,112 19,984
Income taxes payable - 5,054
Deferred tax liability 135 135
Operating lease liabilities 1,739 2,318
Total liabilities 22,986 27,491
Stockholders' equity:
Preferred stock - -
Common stock 13 13
Additional paid-in capital 84,865 84,695
Accumulated deficit (24,216) (17,703)
Accumulated other comprehensive loss (960) (1,069)
Treasury stock, at cost (24,397) (24,336)
Total stockholders' equity 35,305 41,600
Total liabilities and stockholders' equity$58,291 $69,091
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share data)
Three Months Ended September 30, Nine Months Ended September 30,
2024 2023 2024 2023
Net sales$10,691 $10,615 $32,117 $32,987
Cost of sales 2,765 2,689 8,376 8,386
Gross profit 7,926 7,926 23,741 24,601
Operating expenses:
Commissions expense 4,333 4,361 13,022 13,861
Selling, general and administrative expenses 3,868 3,857 11,597 12,169
Total operating expenses 8,201 8,218 24,619 26,030
Loss from operations (275) (292) (878) (1,429)
Other income, net 441 585 1,523 1,708
Income before income taxes 166 293 645 279
Income tax provision 131 121 249 69
Net income$35 $172 $396 $210
Net income per common share:
Basic$0.00 $0.02 $0.03 $0.02
Diluted$0.00 $0.02 $0.03 $0.02
Weighted average common shares outstanding:
Basic 11,471 11,440 11,464 11,432
Diluted 11,490 11,454 11,488 11,449
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
Nine Months Ended September 30,
2024 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income$396 $210
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization 100 130
Net accretion of marketable securities (350) -
Share-based compensation 109 123
Noncash lease expense 825 830
Deferred income taxes 62 (117)
Changes in assets and liabilities:
Inventories 619 (420)
Other current assets (110) (425)
Other assets (250) (92)
Accounts payable (441) (141)
Income taxes payable (3,738) (2,923)
Accrued commissions (34) (315)
Other accrued expenses 179 (58)
Deferred revenue 641 674
Amounts held in eWallets (501) (725)
Operating lease liabilities (851) (812)
Other current liabilities (111) (148)
Net cash used in operating activities (3,455) (4,209)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment (37) (32)
Purchases of marketable securities (44,839) -
Proceeds from maturities of marketable securities 21,786 -
Net cash used in investing activities (23,090) (32)
CASH FLOWS FROM FINANCING ACTIVITIES:
Dividends paid (6,909) (6,911)
Net cash used in financing activities (6,909) (6,911)
Effect of exchange rates on cash, cash equivalents and restricted cash 174 (145)
Net decrease in cash, cash equivalents and restricted cash (33,280) (11,297)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period 56,217 69,746
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period$22,937 $58,449
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
Right-of-use assets obtained in exchange for operating lease liabilities$191 $115

CONTACT:

Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (Hong Kong): +852-3107-0800
Tel (U.S.): 310-541-0888
investor.relations@nhtglobal.com


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.